Physician profile
Murray Rosenbaum
NPI 1639113152
$34,015.30
in general payments reported to CMS, 2019-2025
24 companies · $1,175 in 2025
The $1,175 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $2,317 · 2021: $2,241 · 2022: $1,421 · 2023: $4,721 · 2024: $2,962 · 2025: $1,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,684 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Travel and Lodging: $1,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,684.33 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Travel and Lodging | $1,174.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $20,857.63 | 2019-2024 | Xarelto |
| Medtronic, INC. | $3,463.95 | 2021-2025 | Pulseselect, Arctic Front Advance, Micra |
| Boston Scientific Corporation | $3,148.30 | 2020-2025 | Baylis Medical Company Radiofrequency Puncture Generator, General - Structural Heart, Watchman Flx |
| Abbott Laboratories | $1,466.95 | 2019-2025 | Ensite, Amplatzer, Perclose Prostyle |
| Medtronic Vascular, INC. | $1,105.20 | 2019-2020 | |
| Biosense Webster, INC. | $687.13 | 2021-2025 | Carto 3, Octaray Mapping Catheter, Na |
| Pfizer INC. | $658.99 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $483.97 | 2019-2024 | |
| Cardiva Medical, INC. | $414.11 | 2019-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| E.R. Squibb & Sons, L.L.C. | $400.36 | 2019-2025 | Camzyos, Eliquis |
| Impulse Dynamics (USA) INC. | $290.64 | 2023-2024 | Optimizer, Optimizer |
| Kestra Medical Technology Services, INC. | $266.03 | 2023-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $223.32 | 2019-2024 | Lifevest |
| Lundbeck LLC | $211.29 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $68.17 | 2024 | Arcalyst |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $49.26 | 2022-2023 | |
| Altathera Pharmaceuticals LLC | $48.25 | 2023 | Sotalol Hydrochloride |
| Cvrx, INC. | $44.41 | 2023-2025 | Barostim Neo System |
| Acutus Medical, INC. | $31.94 | 2022 | |
| Baxter Healthcare | $30.39 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Siemens Medical Solutions USA, INC. | $19.23 | 2020 | |
| Philips North America LLC | $17.44 | 2019 | |
| Chiesi USA, INC. | $14.38 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murray Rosenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.